High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: Evaluation of cytolytic activity and IL-2 production

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 312-320

  Moretta, A ^a   Comoli, P ^a   Montagna, D ^a   Gasparoni, A ^a   Percivalle, E ^a   Carena, I ^a   Revello, M G ^a   Gerna, G ^a   Mingrat, G ^a   Locatelli, F ^a   Rondini, G ^a   Maccario, R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

cord blood lymphocytes; cytotoxic activity; EBV lymphoblastoid cell lines; IL 2 production; NK cells

Indexed keywords

INTERLEUKIN 2;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MALE; NATURAL KILLER CELL; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD; VIRUS INFECTION;

EID: 8044245941     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.258-ce1131.x     Document Type: Article

References (37)

1. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non malignant disease. Lancet 1995; 346:214-9.
2. Keever CA, Abu-Hajir M, Graf W. McFadden P, Prichard P, O'Brien J, Flomenberg N. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant 1995; 15:407-19.
3. Atkinson K. Reconstruction of the haemopoietic and immune system after marrow transplantation. Bone Marrow Transplant 1990; 5:209-26.
4. Tosato G, Blaese M. Epstein-Barr virus infection and immunoregulation in man. Adv Immunol 1985; 37:99.
5. Liebowitz D, Kieff E. Epstein-Barr virus. In: Roizman B, Whitley RJ, Lopez C, eds. The human herpesviruses. New York: Raven Press, Ltd., 1993:107-72.
6. Liebowitz D. Epstein-Barr virus - an old dog with new tricks. N Engl J Med 1995; 332:55-57.
7. Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL. Activated lymphocytes during acute Epstein Barr virus infection. J Immunol 1987; 139:3802-7.
8. Wallace LE, Rickinson AB, Rowe M, Moss DJ, Allen DJ, Epstein MA. Stimulation of human lymphocytes with irradiated cells of the autologous Epstein-Barr virus-transformed cell line. Cell Immunol 1982; 67:129-40.
9. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 1992; 176:157-76.
10. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 1992; 176:169-76.
11. + population. Science 1993; 260:98-100.
12. De Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG. T cell response and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. J Exp Med 1994; 179:1297-305.
13. Hill A, Worth A, Elliott T, Rowland-Jones S, Brooks J, Rickinson A, McMichael A. Characterization of two Epstein Barr virus epitopes restricted by HLA-B7. Eur J Immunol 1995; 25:18-24.
14. Henle W, Henle G, Horwitz CA. Infectious mononucleosis and Epstein-Barr virus associated malignancies. In: Lenette EH, Schmidt NJ, eds. Diagnostic procedures for viral rickettsial and chlamydial infections. Washington DC: American Public Health Association, 1979:441-65.
15. + human cytotoxic T lymphocytes. J Immunol 1993; 150:1437-45.
16. Deacock SJ, Schwarer AP, Bridge J, Batchelor JR, Goldman JM, Lechler RI. Evidence that umbilical cord blood contains a higher frequency of HLA class II-specific alloreactive T cells than adult peripheral blood. Transplantation 1992; 53:1128-34.
17. Sharrock CEM, Kaminski E, Man S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 1990; 11:281-6.
18. Torsteinsdottir S, Masucci MG, Lenoir G, Klein G, Klein E. Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers. Cell Immunol 1984; 86:278-86.
19. Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor Vβ sequences. Science 1991; 254:860-2.
20. Slohod KS, Freiberg AS, Allan JE, Rencher SD, Hurwitz JL. T-cell receptor heterogeneity among Epstein Barr virus-stimulated T-cell populations. Virology 1993; 196:179-89.
21. Smith TJ, Terada N, Robinson CC, Gelfand EW. Acute infectious mononucleosis stimulates the selective expression/expansion of Vβ6-1 3 and Vβ7 T cells. Blood 1993; 81:1521-6.
22. Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994; 180:1159-64.
23. + (helper) T cells or exogenous cytokines. J Immunol 1988; 140:1994-8.
24. Stewarl JP, Rooney CM. The interleukin-10 homolog encoded by Epstein Barr virus enhances the reactivation of virus-specific cytotoxic T cell and HLA-unrestricted killer cell responses. Virology 1992; 191:773-82.
25. Harada S, Bechtold T, Seley JK, Purtilo DT. Cell-mediated immunity to Epstein Barr virus (EBV) and natural killer (NK)-cell activity in the X-linked lymphoproliferative syndrome. Int J Cancer 1982; 30:739-44.
26. Schuster V, Kreth HK. Epstein Barr virus infection and associated diseases in children, I. Pathogenesis, epidemiology and clinical aspects. Eur J Pediatr 1992; 151:718-25.
27. Riddler SA, Breinig MC, McKnight JLC. Increased levels of circulating Epstein Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody response are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994; 84:972-84.
28. Frank D, Cesarman E, Liu JF, Michler RE, Knowles DM. Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein Barr virus. Blood 1995; 85:1396-403.
29. + B lymphocytes. Transplantation 1995; 59:637-40.
30. Starzl TE, Porter KA, Iwatsuki S et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporinsteroid therapy, Lancet 1984; 1:583-7.
31. Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusion of donor leukocytes to treat Epstein Barr virus-associated lymphoproliferative disorders after hone marrow transplantation. N Engl J Med 1994; 330:1185-91.
32. Rooney CM, Smith CA, Ng CYC, Loftin S, Li C, Krance RA, Brenner MK. Use of gene-modified virus-specific T lymphocytes to control Epstein Barr-virus-related lymphoproliferation. Lancet 1995; 345:9-12.
33. Masucci MG, Torsteinsdottir S, Colombani J, Brautbar C, Klein E, Klein G. Down-regulation of class I HLA antigens and of the Epstein Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci USA 1987; 84:4567-71.
34. Gregory CD, Murray RJ, Eduards C, Frickinson AB. Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance. J Exp Med 1988; 167:1811-24.
35. Rowe M, Khanna R, Jacob CA et al. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol 1995; 25:1374-84.
36. Rooney CM, Rickinson AB, Moss DJ, Lenoir GM, Epstein MA. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allospecific cytotoxic responses in vitro. Int J Cancer 1984; 34:339-47.
37. Kos FJ, Engkman EG. Immune regulation: a critical link between NK cells and CTLs. Immunol Today 1996; 17:174-6.